Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 594, pseudogene (RN7SL594P)

Target
RN7SL594P
Molecular classification
Pseudogene, Non-coding RNA, Other
01

Overview

RN7SL594P is a pseudogene derived from the 7SL RNA, an integral RNA component of the signal recognition particle (SRP) ribonucleoprotein complex. The canonical 7SL RNA functions in targeting secretory and membrane proteins to the endoplasmic reticulum but RN7SL594P is a non-functional, truncated copy inserted into the genome by reverse transcription. It does not encode a functional protein or participate directly in known biological pathways but may be transcribed in some tissues, potentially exerting regulatory effects such as acting as a competing endogenous RNA (ceRNA) or miRNA sponge, as observed for some transcribed pseudogenes. There is no known association between RN7SL594P and any human disease, nor any drugs or therapies targeting it. The vast majority of 7SL-related loci in the human genome are pseudogenes; only a few encode bona fide functional RNAs. Functionally, the pseudogene may have minor regulatory effects by titrating miRNAs in a tissue-specific manner, but such roles are general and not attributed specifically to RN7SL594P. RN7SL594P does not encode any of the SRP proteins or contribute to the canonical SRP function. There is no evidence for pharmacological intervention or drug development targeting this pseudogene.

Other names
RN7SL594PRNA, 7SL, cytoplasmic 594, pseudogene
02

Mechanism of action

None known.

03

Biological functions

Potential regulation of parental gene expression via ceRNA/miRNA sponge effect (as observed in some pseudogenes)May contribute to epigenetic regulation; some pseudogenes can be transcribed and show histone modifications associated with transcriptional activity
04

Disease associations

Not directly implicated in disease. Some pseudogenes have been studied for roles in cancer biology, but no evidence that RN7SL594P is disease-associated

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 594, pseudogene (RN7SL594P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 594, pseudogene (RN7SL594P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call